Alliance A091103: A multicenter phase II study of the angiopoietin-1 and -2 peptibody trebananib (AMG386) for the treatment of angiosarcoma (AS).
- Citation:
- J Clin Oncol vol 32 (15_suppl) 10568
- Meeting Instance:
- ASCO 2014
- Year:
- 2014
- Type:
- Abstract
- Sub type:
- Poster General
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- pub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Parents:
- None
- Children:
- 2196
- Program:
- OGC
- Primary Committee:
- Experimental
- Sec. Committees:
- Pharmas:
- Grants:
- Corr. Author:
- Sandra P. D'Angelo
- Authors:
- Sandra P. D'Angelo Michelle R. Mahoney Brian Andrew Van Tine Douglas Adkins Maria T. Grosse Perdekamp Mercedes M. Condy Eliza Woodward Hartley Cristina R. Antonescu Gary K. Schwartz William D. Tap
- Networks:
- Study
- Alliance-A091103
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: